Beugeling, M.; Amssoms, K.; Cox, F.; De Clerck, B.; Van Gulck, E.; Verwoerd, J.A.; Kraus, G.; Roymans, D.; Baert, L.; Frijlink, H.W.;
et al. Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study. Pharmaceutics 2019, 11, 510.
https://doi.org/10.3390/pharmaceutics11100510
AMA Style
Beugeling M, Amssoms K, Cox F, De Clerck B, Van Gulck E, Verwoerd JA, Kraus G, Roymans D, Baert L, Frijlink HW,
et al. Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study. Pharmaceutics. 2019; 11(10):510.
https://doi.org/10.3390/pharmaceutics11100510
Chicago/Turabian Style
Beugeling, Max, Katie Amssoms, Freek Cox, Ben De Clerck, Ellen Van Gulck, Jeroen A. Verwoerd, Guenter Kraus, Dirk Roymans, Lieven Baert, Henderik W. Frijlink,
and et al. 2019. "Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study" Pharmaceutics 11, no. 10: 510.
https://doi.org/10.3390/pharmaceutics11100510
APA Style
Beugeling, M., Amssoms, K., Cox, F., De Clerck, B., Van Gulck, E., Verwoerd, J. A., Kraus, G., Roymans, D., Baert, L., Frijlink, H. W., & Hinrichs, W. L. J.
(2019). Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study. Pharmaceutics, 11(10), 510.
https://doi.org/10.3390/pharmaceutics11100510